Eucreas

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg + 850 mg",
  "packaging": "05909990082674 ¦ Rp ¦ EU/1/07/425/001 ¦ 38736\n10 tabl.\n05909990082681 ¦ Rp ¦ EU/1/07/425/002 ¦ 38737\n30 tabl.\n05909990082698 ¦ Rp ¦ EU/1/07/425/003 ¦ 38738\n60 tabl.\nRp ¦ EU/1/07/425/019 ¦ 83764\n10 tabl.\nRp ¦ EU/1/07/425/020 ¦ 83765\n30 tabl.\nRp ¦ EU/1/07/425/021 ¦ 83766\n60 tabl.\nRp ¦ EU/1/07/425/004 ¦ 90551\n120 tabl.\nRp ¦ EU/1/07/425/005 ¦ 90552\n180 tabl.\nRp ¦ EU/1/07/425/006 ¦ 90553\n360 tabl.\nRp ¦ EU/1/07/425/013 ¦ 90554\n120 tabl. (2 x 60)\nRp ¦ EU/1/07/425/014 ¦ 90555\n180 tabl. (3 x 60)\nRp ¦ EU/1/07/425/015 ¦ 90556\n360 tabl. (6 x 60)\nRp ¦ EU/1/07/425/022 ¦ 119778\n120 tabl.\nRp ¦ EU/1/07/425/031 ¦ 119779\n120 tabl. (2 x 60)\nRp ¦ EU/1/07/425/023 ¦ 119780\n180 tabl.\nRp ¦ EU/1/07/425/032 ¦ 119781\n180 tabl. (3 x 60)\nRp ¦ EU/1/07/425/024 ¦ 119782\n360 tabl.\nRp ¦ EU/1/07/425/033 ¦ 119783\n360 tabl. (6 x 60)\n07613421047290 ¦ Rp ¦ EU/1/07/425/039 ¦ 137252\n60 tabl.\nRp ¦ EU/1/07/425/043 ¦ 148831\n120 tabl.\nRp ¦ EU/1/07/425/044 ¦ 148832\n180 tabl. (3x60) tabletek (opakowanie zbiorcze)\nRp ¦ EU/1/07/425/038 ¦ 148833\n30 tabl.\nRp ¦ EU/1/07/425/045 ¦ 148834\n360 tabl. (6x60) tabletek (opakowanie zbiorcze)\nRp ¦ EU/1/07/425/037 ¦ 148835\n10 tabl.\nRp ¦ EU/1/07/425/042 ¦ 148836\n360 tabl.\nRp ¦ EU/1/07/425/040 ¦ 148837\n120 tabl.\nRp ¦ EU/1/07/425/039 ¦ 148838\n60 tabl.\nRp ¦ EU/1/07/425/041 ¦ 148839\n180 tabl.\n05903792743627 ¦ Rp ¦ EU/1/07/425/039 ¦ InPharm Sp. z o.o. ¦ 149779\n60 tabl.",
  "substance": "Vildagliptinum 50 mg + Metformini hydrochloridum 850 mg",
  "common_name": "Vildagliptinum + Metformini hydrochloridum",
  "pl_product_id": "100182274",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}